Fulcrum Therapeutics, Inc.

NASDAQ:FULC

Biotechnology

Healthcare
$3.72 +1.71%

+$0.06 today

Market cap
$284.14M
Beta
2.92
P/E (TTM)
-3.6
EPS (TTM)
-$1.00
52W Low $2.83High $15.74

Volume 0.63M

Average 1.78M

Balance Sheet

Inspect the capital base behind the business.

Assets

$366.28M

FY 2025 · Annual

+40.5% YoY

Liabilities

$17.28M

FY 2025 · Annual

-2.3% YoY

Equity

$349.00M

FY 2025 · Annual

+43.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.41M35.1M25.56M58.21M197.53M
Short-term Investments182.75M167.82M210.66M182.81M154.77M
Net Receivables4.11M1.08M2.25M3.34M1.07M
Inventory(473K)0000
Other Current Assets00005.17M
Total Current Assets226M207.52M242.2M249.92M357.48M
Property, Plant & Equipment (Net)7.37M15.97M12.39M9.58M7.07M
Goodwill00000
Intangible Assets00000
Long-term Investments1.09M1.09M000
Tax Assets00000
Other Non-current Assets542K2.1M3.1M1.21M1.74M
Total Non-current Assets9M19.17M15.5M10.8M8.8M
Total Assets235M226.69M257.69M260.72M366.28M
Account Payables4.79M3.64M2.76M1.16M1.59M
Short-term Debt02.6M000
Tax Payables00000
Deferred Revenue4.71M934K000
Other Current Liabilities4.71M5.34M396K463K258K
Total Current Liabilities19.2M16.73M13.68M11.04M13.05M
Long-term Debt00004.04M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0197K000
Other Non-current Liabilities4.26M0197K197K197K
Total Non-current Liabilities4.26M11.02M8.83M6.64M4.24M
Total Liabilities23.46M27.74M22.5M17.68M17.28M
Common Stock41K52K62K54K67K
Retained Earnings(302.47M)(412.34M)(509.67M)(519.4M)(594.28M)
Accumulated OCI(397K)(797K)(136K)130K174K
Other Stockholders Equity00000
Minority Interest00000
Total Equity211.54M198.94M235.19M243.03M349M
Total Debt013.42M10.82M8.63M6.44M
Net Debt(35.41M)(21.68M)(14.74M)(49.58M)(191.09M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$50.3M
Short-term Investments$283.1M
Receivables$1.8M
Other Current$3.6M
Total Current Assets$338.7M
PP&E (Net)$6.4M
Other Non-current$1.7M
Total Non-current Assets$8.1M
Total Assets$346.8M

Analysis

Selected assets total $346.8M for Latest. The largest visible component is Short-term Investments at $283.1M, about 81.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
425425 filingNov 12, 2026

How much cash does FULC have?

Fulcrum Therapeutics, Inc. (FULC) reported $197.53M in cash and equivalents in fiscal 2025.

How much debt does FULC carry?

Fulcrum Therapeutics, Inc. (FULC) reported $6.44M of total debt, with net debt of -$191.09M.